Top

BMC Cancer

Published in:

Open Access 01-12-2018 | Research article

Women’s knowledge and attitudes related to cervical cancer and cervical cancer screening in Isiolo and Tharaka Nithi counties, Kenya: a cross-sectional study

Authors: Murithi Gatumo, Susan Gacheri, Abdul-Rauf Sayed, Andrew Scheibe

Published in: BMC Cancer | Issue 1/2018

Abstract

Background

Cervical cancer is the most common cancer among women in Kenya. However, only 3% of women are routinely screened. This study aimed to assess women’s knowledge and attitudes towards cervical cancer and cervical cancer screening in Kenya’s Isiolo and Tharaka Nithi counties.

Methods

A cross-sectional survey was conducted between January and March 2017. Using a multistage cluster sampling methodology, 451 women 18 years of age and older participated in the study. Interviewers administered a 35-item questionnaire collecting demographic information, knowledge of risk factors and attitudes towards cervical cancer and cervical cancer screening. Bivariate and multivariate analyses of cervical cancer knowledge and demographic characteristics were conducted.

Results

The response rate for the study was 98% (451/460). Two-thirds of the study participants originated from Tharaka Nithi county (n = 318). Respondents reported a median age of 32; 70.5% were married; and 35.0% had primary education. Eighty percent of the participants were aware of cervical cancer, 25.6% of whom had previously undergone a cervical screening examination, and 44.4% had above-average knowledge of risk factors of cervical cancer. Knowledge of cervical cancer risk factors was significantly associated with employment status (adjusted odds ratio = 1.6; 95% CI: 1.0–2.6) and county of origin (adjusted odds ratio = 2.8; 95% CI: 1.6–5.0). Almost all (89.2%) of those who had heard of cervical cancer categorised it as “scary”. There was a marginal significant difference in the overall attitude assessment score towards cervical cancer between participants from Isiolo and Tharaka Nithi counties; the mean (SD) score was 2.13 (0.34) and 2.20 (0.30) respectively. The score was comparatively higher among participants residing in Tharaka Nithi (95% CI: 0.002–0.146; p = 0.043).

Conclusions

Interventions to increase cervical cancer knowledge are needed in Isiolo and Tharaka Nithi counties, Kenya. Additional research is needed to further understand and assess the effectiveness of different strategies to improve attitudes regarding cervical cancer in order to increase the uptake of screening services, particularly among less-educated women and those in hard-to-reach areas.

Available only for authorised users

World Health Organization. Human papilloma virus and cervical cancer: fact sheet. Geneva: WHO; 2016.

McFarland DM. Cervical cancer and pap smear screening in Botswana: knowledge and perceptions. Int Nurs Rev. 2003;50:167–75. Available from: http://doi.wiley.com/10.1046/j.1466-7657.2003.00195.x CrossRefPubMed

Louie KS, De Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Heal. 2009;14:1287–302. Available from: http://doi.wiley.com/10.1111/j.1365-3156.2009.02372.x CrossRef

Francis SA, Nelson J, Liverpool J, Soogun S, Mofammere N, Thorpe RJ. Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg. South Africa Vaccine. 2010;28:8026–32. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0264410X10012727 PubMed

Lyimo FS, Beran TN. Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: three public policy implications. BMC Public Health. 2012;12:22. Available from: http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-12-22 CrossRefPubMedPubMedCentral

International Agency for Research on Cancer. World cancer report 2014. World heal. Organ. Lyon: WHO. p. 2014. Available from: http://www.who.int/cancer/publications/WRC_2014/en/.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. IJC. 2015;136:E359–86.

Paavonen J, Naud P, Salmerón J, Wheeler C, Chow S-N, Apter D, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301–14. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673609612484 CrossRefPubMed

Korir A, Okerosi N, Ronoh V, Mutuma G, Parkin M. Incidence of cancer in Nairobi, Kenya (2004-2008). Int J Cancer. 2015;137:2053–9. Available from: http://doi.wiley.com/10.1002/ijc.29674 CrossRefPubMed

10.

Rosser JI, Hamisi S, Njoroge B, Huchko MJ. Barriers to cervical cancer screening in rural Kenya: perspectives from a provider survey. J Community Health. 2015;40:756–61. https://doi.org/10.1007/s10900-015-9996-1.CrossRefPubMed

11.

Buchanan Lunsford N, Ragan K, Lee Smith J, Saraiya M, Aketch M. Environmental and psychosocial barriers to and benefits of cervical Cancer screening in Kenya. Oncologist. 2017;22:173–81. Available from: http://theoncologist.alphamedpress.org/lookup/doi/10.1634/theoncologist.2016-0213 CrossRefPubMedPubMedCentral

12.

Kenya National Bureau of Statistics. Kenya demographic and health survey. Nairobi: Kenya National Bureau of Statistics; 2014.

13.

Commission on Revenue Allocation. Kenya County Fact Sheets. Second Edition. Nairobi: CRA; 2013.

14.

KIPRA. Kenya economic report 2013. Nairobi: KIPPRA; 2013.

15.

Lwanga S, Lemeshow S. Sample size determination in health studies, a practical manual. Geneva: WHO; 1991.

16.

Erhlich R, Joubert G. Populatoin and sampling. Epidemiol. A Res. Man. South Africa. Cape Town: Oxford University Press; 2014. p. 98–109.

17.

Kenya National Bureau of Statistics. Population distribution by age, sex, county and district. Nairobi: Kenya National Bureau of Statistics; 2009.

18.

Gözüm S, Karayurt Ö, Kav S, Platin N. Effectiveness of peer education for breast Cancer screening and health beliefs in eastern Turkey. Cancer Nurs. 2010;33:213–20. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002820-201005000-00007 CrossRefPubMed

19.

Champion V. Revised susceptibility, benefits, and barriers scale for mammography screening. Res Nurs Health. 1999;22:341–8.CrossRefPubMed

20.

Gullatte MM, Brawley O, Kinney A, Powe B, Mooney K. Religiosity, spirituality, and Cancer fatalism beliefs on delay in breast Cancer diagnosis in African American women. J Relig Health. 2010;49:62–72. Available from: http://link.springer.com/10.1007/s10943-008-9232-8 CrossRefPubMed

21.

Mayo RM, Ureda JR, Parker VG. Importance of fatalism in understanding mammography screening in rural elderly women. J Women Aging. 2001;13:57–72. Available from: http://www.tandfonline.com/doi/abs/10.1300/J074v13n01_05 CrossRefPubMed

22.

Getahun F, Mazengia F, Abuhay M, Birhanu Z. Comprehensive knowledge about cervical cancer is low among women in Northwest Ethiopia. BMC Cancer. 2013;13:2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23282173 CrossRefPubMedPubMedCentral

23.

Kassahun CW, Mekonen AG. Knowledge, attitude, practices and their associated factors towards diabetes mellitus among non diabetes community members of Bale Zone administrative towns, South East Ethiopia. PLoS One. 2017;12:e0170040. Available from: http://dx.plos.org/10.1371/journal.pone.0170040 CrossRefPubMedPubMedCentral

24.

Feldt L. The approximate sampling distribution of Kuder-Richardson reliability coefficient twenty. Psychometrika. 1965;30:357–70.CrossRefPubMed

25.

Nunnally J, Bernstein I. Psychometric theory. New York: McGraw-Hill; 1994.

26.

Anderson DL, Fisher KM, Norman GJ. Development and evaluation of the conceptual inventory of natural selection. J Res Sci Teach. 2002;39:952–78. Available from: http://doi.wiley.com/10.1002/tea.10053 CrossRef

27.

Lauritsen JM, Bruus M. EpiData (version 3). Odense: The EpiData Association; 2003.

28.

StataCorp. Stata: Release 13. Statistical software. College Station: StataCorp LP; 2013.

29.

Mitiku I, Tefera F. Knowledge about Cervical Cancer and Associated Factors among 15–49 Year Old Women in Dessie Town, Northeast Ethiopia. PLoS One. 2016;11:e0163136. Available from: http://dx.plos.org/10.1371/journal.pone.0163136 CrossRefPubMedPubMedCentral

30.

Aweke YH, Ayanto SY, Ersado TL. Knowledge, attitude and practice for cervical cancer prevention and control among women of childbearing age in Hossana Town, Hadiya zone, Southern Ethiopia: Community-based cross-sectional study. PLoS ONE. 2017;12(7):e0181415. https://doi.org/10.1371/journal.pone.0181415.

31.

Almobarak AO, Elbadawi AA, Elmadhoun WM, Elhoweris MH, Ahmed MH. Knowledge, attitudes and practices of Sudanese women regarding the pap smear test and cervical Cancer. Asian Pac. J. Cancer Prev. 2016;17:625–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26925654 CrossRefPubMed

32.

Muthoni AM, Mutuma, Ochieng OG, Mburugu KR, Samson N, Taratisio T, Gacheri R. Socio-demographic characteristics influencing uptake of screening for cervical cancer in women aged 18-49 years in Imenti North Sub-county, Meru County, Kenya. Sci J Prim Health; 2016;4:94–9.

33.

Hailu A, Mariam DH. Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study. BMC Cancer. 2013;13:69. Available from: http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-13-69 CrossRefPubMedPubMedCentral

34.

Wamburu K, Busakhala N, Owuor K, Nyagero J. Association between stage at diagnosis and knowledge on cervical cancer among patients in a Kenyan tertiary hospital: a cross-sectional study. Pan Afr Med J. 2016;25:15.PubMedPubMedCentral

35.

De Ver Dye T, Bogale S, Hobden C, Tilahun Y, Hechter V, Deressa T, et al. A mixed-method assessment of beliefs and practice around breast cancer in Ethiopia: implications for public health programming and cancer control. Glob Public Health. 2011;6:719–31. Available from: http://www.tandfonline.com/doi/abs/10.1080/17441692.2010.510479

36.

Vermandere H, van Stam M-A, Naanyu V, Michielsen K, Degomme O, Oort F. Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data. Global. Health. Glob Health; 2016;12:72. Available from: http://globalizationandhealth.biomedcentral.com/articles/10.1186/s12992-016-0211-7

37.

Ministry of Public Health and Sanitation, Ministry of Medical Services. National Guidelines for Prevention and Management of Cervical, Breast and Prostate Cancers. Nairobi: Kenyan Ministry of Public Health and Sanitation; 2012. p. 110.

38.

American Cancer Society Global Health Department. Activity in Kenya. Washington: American Cancer Society; 2015.

39.

Were E, Nyaberi Z, Buziba N. Perceptions of risk and barriers to cervical cancer screening at Moi teaching and referral hospital (MTRH), Eldoret, Kenya. Afr. Health Sci. 2011;11:58–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21572858 PubMedPubMedCentral

40.

Johnson LG, Armstrong A, Joyce CM, Teitelman AM, Buttenheim AM. Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: a systematic review. Implement Sci. 2018;13:1–18.CrossRef

41.

Rosser JI, Njoroge B, Huchko MJ, Sciences R, Francisco S. Changing knowledge, attitudes, and behaviors regarding cervical cancer screening: The effects of an educational intervention in rural Kenya. Patient Educ Couns. 2015;98(7):884–9. https://doi.org/10.1016/j.pec.2015.03.017.

42.

Abiodun OA, Olu-Abiodun OO, Sotunsa JO, Oluwole FA. Impact of health education intervention on knowledge and perception of cervical cancer and cervical screening uptake among adult women in rural communities in Nigeria. BMC Public Health. 2014;14:814. Available from: http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-814 CrossRefPubMedPubMedCentral

43.

Mbachu C, Dim C, Ezeoke U. Effects of peer health education on perception and practice of screening for cervical cancer among urban residential women in south-East Nigeria: a before and after study. BMC Womens Health BMC Womens Health. 2017;17:1–8.CrossRef

Title: Women’s knowledge and attitudes related to cervical cancer and cervical cancer screening in Isiolo and Tharaka Nithi counties, Kenya: a cross-sectional study
Authors: Murithi Gatumo
Susan Gacheri
Abdul-Rauf Sayed
Andrew Scheibe
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-018-4642-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma

Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study

Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy

Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients

Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients

CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer